Recent Updates
Recently added Catalysts
ORIC Positive Sentiment

ORIC Pharmaceuticals to Participate in the Jefferies Healthcare Conference

Wednesday, May 31, 2023 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: ORIC Pharmaceuticals, Inc. announced its participation in the Jefferies Healthcare Conference on June 7, 2023, where management will engage in a fireside chat. This event provides ORIC an opportunity to discuss their clinical-stage oncology developments and mechanisms of therapeutic resistance. The live discussion will be accessible via the company's investor webpage, with a replay available for 90 days post-event.
Price reaction · baseline $5.035 (2023-05-30 close) · hit after-hours · 1 other ORIC headline(s) in the window, move may be shared
day 0 close
+0.1%

Market Sentiment Analysis

POSITIVE FACTORS

  • Participation in a prominent healthcare conference enhances visibility.
  • Opportunity to showcase their innovations in oncology therapies.
  • Engagement with investors through live webcasts demonstrates transparency.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+58%
120-day peak, hindsight
Typical move
10.1%
average across 6 past catalysts
Cash runway
~36 mo
Minimal dilution risk
Lead asset
ORIC-944
Phase 1 · Metastatic Prostate Cancer

Full Press Release Details

SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, May 31, 2023 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced that management will participate in a fireside chat at the Jefferies Healthcare Conference on Wednesday, June 7, 2023, at 10:00 a.m. ET.
The live webcast of the discussion will be available through the investor section of the company’s website at www.oricpharma.com. A replay of the webcast will be available for 90 days following the event.
About ORIC Pharmaceuticals, Inc.

Frequently Asked Questions

When will ORIC Pharmaceuticals participate in the Jefferies Healthcare Conference?

ORIC Pharmaceuticals will participate on June 7, 2023, at 10:00 a.m. ET.

Where can I watch the ORIC Pharmaceuticals webcast?

The webcast will be available on ORIC's investor section at www.oricpharma.com.

How long will the webcast replay be available?

The replay of the webcast will be accessible for 90 days after the event.

What does ORIC Pharmaceuticals focus on?

ORIC Pharmaceuticals focuses on developing treatments for therapeutic resistance.

Who is the CFO of ORIC Pharmaceuticals?

The CFO of ORIC Pharmaceuticals is Dominic Piscitelli.

ShareAdd on Google
Tags: ORIC Viatris Investor Conferences Healthcare ORIC Pharmaceuticals Jefferies Healthcare Conference oncology therapeutic resistance clinical stage
Last updated: May 31, 2023

Biotech snapshot

Cash runway
$388M liquidity · $11M/mo burn
~36 mo
Minimal dilution risk
Lead asset
ORIC-944Phase 1
Metastatic Prostate Cancer →

Catalyst track record

+58%
best trade around ORIC's most recent catalyst

Peak hindsight return over a 120-day window, across 6 tracked FDA/PDUFA catalysts for ORIC.

See every catalyst's timing & PoA →